FDA sounds alert on anemia drugs

JAMA. 2007 May 2;297(17):1868-9. doi: 10.1001/jama.297.17.1868.
No abstract available

Publication types

  • News

MeSH terms

  • Anemia / drug therapy*
  • Drug Labeling
  • Erythropoietin / therapeutic use*
  • Humans
  • Recombinant Proteins
  • Risk
  • United States
  • United States Food and Drug Administration*

Substances

  • Recombinant Proteins
  • Erythropoietin